Alzheimer's Disease Clinical Trials in Phoenix

Showing 61-80 of 237 trials

18F-AV-1451 High Resolution Autopsy Study

NCT02350634

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

Alzheimer's Disease

Avid Radiopharmaceuticals3 participantsStarted Nov 2016

Phoenix, Arizona, United States • San Francisco, California, United States

TERMINATEDPhase 3< 1 mile

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

NCT04464564

This study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

Agitation in Patients With Dementia of the Alzheimer's Type

Otsuka Pharmaceutical Development & Commercialization, Inc.241 participantsStarted Sep 2020

Phoenix, Arizona, United States • Anaheim, California, United States • Costa Mesa, California, United States +103 more locations

18F-AV-1451 High Resolution Autopsy Study

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Alzheimer's Disease Trials in Other Cities

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

A Study to Learn About the Safety of BIIB080 Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

Alzheimer's Disease Neuroimaging Initiative 2

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

A Study of Seltorexant in Participants With Probable Alzheimer's Disease

North American Prodromal Synucleinopathy Consortium

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

Advancing Understanding of Transportation Options

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Goals of Care Conversations Study

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Other Conditions in Phoenix